NCT06202781View on ClinicalTrials.gov

Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy

RecruitingOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2024

Conditions
Gastric CancerTumor MicroenvironmentImmunotherapyChemotherapy
Interventions
DRUG

SOX plus PD-1 inhibitor

S-1, Oxaliplatin and nivolumab/sintilimab

PROCEDURE

Gastroscopic biopsy

Gastroscopy and biopsy

Trial Locations (1)

100853

RECRUITING

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER